- Home
- STRR vs XXII Comparison
STRR vs XXII Comparison
Compare STRR & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- XXII
- Stock Information
- Founded
- STRR 1985
- XXII 1998
- Country
- STRR United States
- XXII United States
- Employees
- STRR N/A
- XXII N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- XXII Medicinal Chemicals and Botanical Products
- Sector
- STRR Health Care
- XXII Health Care
- Exchange
- STRR Nasdaq
- XXII Nasdaq
- Market Cap
- STRR 6.3M
- XXII 7.0M
- IPO Year
- STRR N/A
- XXII N/A
- Fundamental
- Price
- STRR $2.00
- XXII $8.09
- Analyst Decision
- STRR Strong Buy
- XXII
- Analyst Count
- STRR 1
- XXII 0
- Target Price
- STRR $5.00
- XXII N/A
- AVG Volume (30 Days)
- STRR 21.4K
- XXII 38.2K
- Earning Date
- STRR 08-12-2025
- XXII 08-12-2025
- Dividend Yield
- STRR N/A
- XXII N/A
- EPS Growth
- STRR N/A
- XXII N/A
- EPS
- STRR N/A
- XXII N/A
- Revenue
- STRR $57,165,000.00
- XXII $23,869,000.00
- Revenue This Year
- STRR $33.64
- XXII $22.41
- Revenue Next Year
- STRR $22.87
- XXII $76.35
- P/E Ratio
- STRR N/A
- XXII N/A
- Revenue Growth
- STRR 34.33
- XXII N/A
- 52 Week Low
- STRR $1.72
- XXII $6.28
- 52 Week High
- STRR $5.35
- XXII $2,837.04
- Technical
- Relative Strength Index (RSI)
- STRR 45.82
- XXII 24.50
- Support Level
- STRR $1.95
- XXII $6.81
- Resistance Level
- STRR $2.02
- XXII $9.50
- Average True Range (ATR)
- STRR 0.07
- XXII 1.70
- MACD
- STRR -0.00
- XXII -0.32
- Stochastic Oscillator
- STRR 36.84
- XXII 20.46
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company. It operates in two segments: Building Solutions segment, through KBS, EBGL and TT, it services residential and commercial construction projects by manufacturing modular housing units, structural wall panels, permanent wood foundation systems, other engineered wood products, and supply general contractors with building materials; and Investments segment, which holds corporate-owned real estate, currently includes one manufacturing facility and the equipment for another manufacturing facility in Maine that it leases back to KBS and its manufacturing facility in Wisconsin that it leases back to TT. The company derives maximum revenue from Building Solutions Segment.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.